Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

More Than Just A VAD Maker: HeartWare Broadens Heart Failure Focus With Valtech Buy

This article was originally published in The Gray Sheet

Executive Summary

The deal will make HeartWare more of a go-to firm for heart-failure specialists, executives say. It comes soon after St. Jude Medical announced its acquisition of Thoratec, another VAD-focused firm whose technology will now be sold alongside a broader set of tools for heart-failure caregivers.


Related Content

Medtechs Bet On Transcatheter Mitral Valve Repair
HeartWare Drops Valtech Deal Under Shareholder Pressure; Stays Focused On VADs
Despite Unknowns, Companies Bet On Transcatheter Mitral Valve Repair
M&A Deals Drop In 2015, With IVD-Sector Transactions Still Leading The Pack
Transcatheter Mitral Valve Therapy: Opportunities And Challenges
VADs Set To Enter Big Leagues With St. Jude's Plan To Acquire Thoratec


Related Companies

Related Deals